Drug Distribution Journal Scientific Journal
The process of transferring a drug from the bloodstream to
tissues is referred to as distribution. The same principles that govern drug absorption (e.g. ionization of a drug, lipophillicity of a drug, size of a drug, pH of the environment, etc.) also govern the speed and extent that a drug will distribute to various
tissues in the body. In addition, there are additional factors at play, particularlyCommonly,
drugs bind non-specifically to albumin within the plasma. Additionally, one drug, digoxin, tends to bind non-specifically to striated muscle, when, in fact, its desired actions occur within the heart. When
drugs bind non-specifically to
proteins, their movement is restricted. That is because the large proteins to which they are bound will not be able to readily distribute to other parts of the body. The protein acts as a “reservoir” of sorts. As long as a drug is bound non-specifically to a protein, it cannot have a therapeutic action, nor can it's eliminated (metabolized hepatically by the liver or excreted by the kidneys). Non-specific binding to
drugs can also play a role in drug-drug interactions; if two or more
drugs are competing for the same binding site, one drug will displace the other, thereby, leading to potential toxicity caused by the drug that was displaced.
High Impact List of Articles
-
The role of corticosteroids in the management of kidney stones disease: a systematic review
Ahmed Nouri*, Mohamed Azmi Hassali & Azhar Amir Hamza
Research Article: Clinical Practice
-
The role of corticosteroids in the management of kidney stones disease: a systematic review
Ahmed Nouri*, Mohamed Azmi Hassali & Azhar Amir Hamza
Research Article: Clinical Practice
-
Lenalidomide Induced
Stroke in Multiple Myeloma
Shridhar P*, Khalil R,
Lasorda D, Chun Y
Review Article: Clinical Practice
-
Lenalidomide Induced
Stroke in Multiple Myeloma
Shridhar P*, Khalil R,
Lasorda D, Chun Y
Review Article: Clinical Practice
-
Mean platelet volume measurements affecting evaluation of parameters in dialysis patients (The affective of mean platelet volume)
Nilgul Akalin, Mehmet Koroglu, Selcuk Sezikli, Senol Senturk and Murat Asik
Research Article: Clinical Practice
-
Mean platelet volume measurements affecting evaluation of parameters in dialysis patients (The affective of mean platelet volume)
Nilgul Akalin, Mehmet Koroglu, Selcuk Sezikli, Senol Senturk and Murat Asik
Research Article: Clinical Practice
-
The challenges of treating the mentally ill in a prison setting: the European perspective
N Konrad, A Opitz-Welke
Perspective Article: Clinical Practice
-
The challenges of treating the mentally ill in a prison setting: the European perspective
N Konrad, A Opitz-Welke
Perspective Article: Clinical Practice
-
Bulletin Board: Volume 8 Issue 1
Bulletin Board: Clinical Practice
-
Bulletin Board: Volume 8 Issue 1
Bulletin Board: Clinical Practice
-
Corrigendum: Volume 7 Issue 1
Appendices: Clinical Practice
-
Corrigendum: Volume 7 Issue 1
Appendices: Clinical Practice
-
Opioids: maximizing efficacy, minimizing adverse effects
Howard S Smith
Foreword: Clinical Practice
-
Opioids: maximizing efficacy, minimizing adverse effects
Howard S Smith
Foreword: Clinical Practice
-
Ranolazine extended-release for chronic angina
Laura M Gruen and Carl J Pepine
Drug Evaluation: Clinical Practice
-
Ranolazine extended-release for chronic angina
Laura M Gruen and Carl J Pepine
Drug Evaluation: Clinical Practice
-
Dr Charles Drake speaks to Laura Dormer, Editor
Charles Drake
Interview: Clinical Practice
-
Dr Charles Drake speaks to Laura Dormer, Editor
Charles Drake
Interview: Clinical Practice
-
Compliance and the treatment of hypertension: where are we now?
Sunil K Nadar and Gregory YH Lip
Editorial: Clinical Practice
-
Compliance and the treatment of hypertension: where are we now?
Sunil K Nadar and Gregory YH Lip
Editorial: Clinical Practice
Relevant Topics in Clinical